Tomorrow Capital | Investment Thesis & Preferences

01Investment Thesis

New-age Indian consumer brands can leverage the shift to domestic consumption and urbanization through innovative products, reimagined distribution, and supply chains. We help stellar early-stage entrepreneurs build transformative consumption-themed businesses with patient capital and hands-on operational support.

Exclusion Criteria

Avoids a spray-and-pray approach; makes a limited number of select investments rather than broad diversification.

02Investment Team

RS

Rahul Saha

Senior Principal

AS

Aditya Singh

Principal

AJ

Alan James

Principal

AA

Anshul Ajwani

Associate

DA

Deep Arora

Associate, Investment & Portfolio Analytics

SA

Shivam Amla

Investment Professional

03F4 Research Brief

Tomorrow Capital Research

Investment Thesis

Tomorrow Capital is a $100 million early-stage strategic investment fund based in Mumbai, founded in 2017, that positions itself as an operator-led "partner, not investor." The firm's stated mission is to help strong founders build India's leading consumer brands of the future, betting on the country's exponential growth in domestic consumption and urbanization. It looks for early-stage entrepreneurs with strong, differentiated business models building transformative businesses around consumption themes, and backs them with long-term patient capital plus hands-on operational support in finance, compliance, taxation, cash-flow management, and asset procurement.

Sector Focus

Tomorrow Capital is sector-agnostic within the broad "new-age Indian consumer brand" category, but its actual portfolio clusters around consumer healthcare (pharmacy retail, dialysis care, IVF/fertility), consumer fintech (home loans, wealth management platforms), edtech (higher-education admissions, kids' upskilling), and D2C consumer products (home interiors, personal care). The firm explicitly avoids a "spray and pray" approach, keeping the number of active portfolio companies deliberately small so it can be deeply involved with each one.

Stage Focus

The fund invests at the early stage, spanning seed through Series A/B, with a preference for being one of the first institutional checks into a company (e.g., Easiloan's seed round, VitusCare's Series A) and continuing to support companies through follow-on rounds (Bonito Designs, Leverage Edu).

Check Size

Observed individual investments range from roughly ₹8 crore (~$1M, Easiloan seed) up to ₹50+ crore (~$6M, cumulative in Bonito Designs across rounds), with typical single-round checks in the $1M-$3M range (VitusCare's $2.7M Series A, India IVF's $1.25M round). The $100M fund size supports meaningful reserves for follow-ons into winners.

Lead Tendency

Tomorrow Capital frequently leads or spearheads the rounds it participates in — it led VitusCare's Series A, backed Easiloan's maiden round, and "backed" Bonito Designs' pre-Series A round as a lead-style strategic investor.

Recent Activity

The firm has stayed active through 2024-2025: it spearheaded a $2.7M Series A in kidney-care startup VitusCare (April 2024), invested $1.25M in fertility-clinic chain India IVF (November 2024), and provided follow-on capital as part of Bonito Designs' ~$9.5M round alongside existing investors (July 2025). It also backed personal-care D2C brand IndiShreshtha (Shaastram), founded in April 2024.

Portfolio Highlights

Notable companies include Zeno Health (retail generics pharmacy chain, Tomorrow Capital's first exit with a 7x return after growing from 3 to 150+ stores), Bonito Designs (home interior design, fastest in its category to ₹100 crore ARR), Leverage Edu (global higher-education admissions platform, backed across Series A and B), BeyondSkool (live online upskilling academy for kids, 10x growth within a year), Easiloan (India's first digital home-loan platform), VitusCare (North India's fastest-growing dialysis chain), Fintso (B2B2C wealth-management platform-as-a-service for independent financial advisors), India IVF (profitable, fast-growing IVF chain), and Shaastram/IndiShreshtha (D2C personal-care brand backed by actress Bhumi Pednekar as brand ambassador).

Team

Rahul Saha, Senior Principal — leads early-stage consumer investments; an IIM Bangalore alum and one of the most publicly visible faces of the firm in press commentary on operator-led venture investing.
Aditya Singh, Principal — investment team.
Alan James, Principal — investment team.
Anshul Ajwani, Associate — leads new investments and portfolio value creation; background across fintech operating roles before joining Tomorrow Capital.
Deep Arora, Associate, Investment & Portfolio Analytics — portfolio analytics and diligence support.
Shivam Amla, Investment Professional — investment team.

Decision Process

As a small, hands-on team without a large investment committee structure, decisions appear to run through the core partnership/investment team rather than a formal multi-tier IC.

Founder Preferences

Tomorrow Capital gravitates toward founders building consumer-facing businesses with strong, differentiated unit economics who want an investor willing to embed operationally — helping build finance, compliance, and growth functions rather than just writing a check.

Geographic Focus

Exclusively India-focused, headquartered in Mumbai (4th Floor, Lodha Excelus, Apollo Mills Compound, Mahalaxmi), with portfolio companies spanning Mumbai, Bangalore, Gurgaon, and other Indian metros.

04Selected Portfolio